Augurex (@augurex) 's Twitter Profile
Augurex

@augurex

Augurex is transforming health management and improving patient outcomes.
Developer of 14-3-3η Blood Test for Rheumatoid Arthritis.

ID: 610423137

linkhttp://www.augurex.com calendar_today16-06-2012 23:07:26

554 Tweet

1,1K Followers

1,1K Following

Augurex (@augurex) 's Twitter Profile Photo

Getting a diagnosis can be hard for patients who are seronegative. The SeroNeg RAdx4 panel for RA improves diagnosis of established or early RA, especially in individuals who are seronegative for RF and Anti-CCP, and may also help predict disease severity. labcorp.com/tests/520305/s…

Getting a diagnosis can be hard for patients who are seronegative. The SeroNeg RAdx4 panel for RA improves diagnosis of established or early RA, especially in individuals who are seronegative for RF and Anti-CCP, and may also help predict disease severity.
labcorp.com/tests/520305/s…
Augurex (@augurex) 's Twitter Profile Photo

Enhance the diagnosis of rheumatoid arthritis in early or established disease while predicting disease severity with the RAdx6 profile. labcorp.com/tests/520304/r…

Enhance the diagnosis of rheumatoid arthritis in early or established disease while predicting disease severity with the RAdx6 profile.
labcorp.com/tests/520304/r…
Augurex (@augurex) 's Twitter Profile Photo

Prolonged joint pain can be a sign of arthritis, but early treatment can help. Learn about your risk and receive a free personalized action plan to review with your doctor. digitalhealth.augurex.com

Prolonged joint pain can be a sign of arthritis, but early treatment can help. Learn about your risk and receive a free personalized action plan to review with your doctor.
digitalhealth.augurex.com
Augurex (@augurex) 's Twitter Profile Photo

Honored to be recognized by Pacific Economic Development Canada! This $5M funding will fast-track the launch of our Ankylosing Spondylitis Blood Test, driving our global growth and innovation. #CIW24 #HealthcareInnovation

Augurex (@augurex) 's Twitter Profile Photo

Do you have persistent joint pain? Act quickly before joint damage occurs. Find out if you're at risk of Rheumatoid Arthritis. augurex.com/are-you-at-ris…

Do you have persistent joint pain? Act quickly before joint damage occurs. Find out if you're at risk of Rheumatoid Arthritis.
augurex.com/are-you-at-ris…
Augurex (@augurex) 's Twitter Profile Photo

Early rheumatoid arthritis detection transforms outcomes. Diagnose RA with RheumAssure®. labcorp.com/tests/504509/r…

Early rheumatoid arthritis detection transforms outcomes. Diagnose RA with RheumAssure®.
labcorp.com/tests/504509/r…
Augurex (@augurex) 's Twitter Profile Photo

Joint stiffness for more than 6 weeks may be related to arthritis. Learn about your risk and why early treatment is important to help you stay active. digitalhealth.augurex.com

Joint stiffness for more than 6 weeks may be related to arthritis. Learn about your risk and why early treatment is important to help you stay active.
digitalhealth.augurex.com
Augurex (@augurex) 's Twitter Profile Photo

Act confidently with precise rheumatoid arthritis therapy decisions by testing 14-3-3η (eta). labcorp.com/tests/504550/1…

Act confidently with precise rheumatoid arthritis therapy decisions by testing 14-3-3η (eta).
labcorp.com/tests/504550/1…
Augurex (@augurex) 's Twitter Profile Photo

Seronegative rheumatoid arthritis (RA) can go overlooked. The RheumAssure® panel combines traditional RF and anti-CCP markers with 14-3-3η (eta) to accurately diagnose early and established RA even when negative for RF and anti-CCP. labcorp.com/tests/504509/r…

Seronegative rheumatoid arthritis (RA) can go overlooked. The RheumAssure® panel combines traditional RF and anti-CCP markers with 14-3-3η (eta) to accurately diagnose early and established RA even when negative for RF and anti-CCP.
labcorp.com/tests/504509/r…
Augurex (@augurex) 's Twitter Profile Photo

Persistent joint discomfort can be an early sign of inflammatory arthritis, but early treatment improves mobility and prevents joint damage. Take an assessment to learn about your risk. digitalhealth.augurex.com

Persistent joint discomfort can be an early sign of inflammatory arthritis, but early treatment improves mobility and prevents joint damage. Take an assessment to learn about your risk.
digitalhealth.augurex.com
Augurex (@augurex) 's Twitter Profile Photo

We’re thrilled to receive the 2024 @LifeSciences_BC Emerging Company of the Year Award presented by Farris! These awards celebrate achievements in BC’s life sciences sector. Join us at the awards ceremony on September 10!  Read More: lifesciencesbc.ca/lsbc-news/life… #LSBCawards

We’re thrilled to receive the 2024 @LifeSciences_BC  Emerging Company of the Year Award presented by Farris! These awards celebrate achievements in BC’s life sciences sector. Join us at the awards ceremony on September 10! 

Read More: lifesciencesbc.ca/lsbc-news/life… 

#LSBCawards
Augurex (@augurex) 's Twitter Profile Photo

The most comprehensive rheumatoid arthritis panel - 6 biomarkers for accurate and early diagnosis. labcorp.com/tests/520304/r…

The most comprehensive rheumatoid arthritis panel - 6 biomarkers for accurate and early diagnosis.
labcorp.com/tests/520304/r…
Augurex (@augurex) 's Twitter Profile Photo

We’re excited to announce that Augurex will present two posters at ADLM 2024! Dr. Navneet Sidhu will discuss our latest research on the 14-3-3η finger pick LFT and diagnostic autoantibody assays for axSpA. Learn more: bit.ly/4feOSdn bit.ly/4di9u2y #axspa #AS

We’re excited to announce that Augurex will present two posters at ADLM 2024! Dr. Navneet Sidhu will discuss our latest research on the 14-3-3η finger pick LFT and diagnostic autoantibody assays for axSpA.

Learn more:
bit.ly/4feOSdn
bit.ly/4di9u2y

#axspa #AS
Augurex (@augurex) 's Twitter Profile Photo

We are thrilled to announce that Neil Klompas has joined Augurex as our new President and CEO. Neil brings a wealth of experience and a passion for advancing healthcare. Learn more about this exciting development on our website: augurex.com/leadership-upd…

We are thrilled to announce that Neil Klompas has joined Augurex as our new President and CEO. Neil brings a wealth of experience and a passion for advancing healthcare.

Learn more about this exciting development on our website: augurex.com/leadership-upd…
Augurex (@augurex) 's Twitter Profile Photo

14-3-3η(eta), a clinically proven biomarker for earlier, more accurate RA diagnosis, prognosis and monitoring. Make informed decisions on treatment course with accurate diagnosis and monitoring of RA. augurex.com/prevent-perman…

14-3-3η(eta), a clinically proven biomarker for earlier, more accurate RA diagnosis, prognosis and monitoring. Make informed decisions on treatment course with accurate diagnosis and monitoring of RA.
augurex.com/prevent-perman…
Augurex (@augurex) 's Twitter Profile Photo

We’re thrilled to announce that we’ll be presenting our research on the 14-3-3η auto-antibody test at #SpondyloCongress 2024 in Ghent, Belgium. Join us on Sep 6th as we explore its potential in advancing #AxSpA diagnosis and care. #AS #axialSpa Learn more bit.ly/spa-congress

We’re thrilled to announce that we’ll be presenting our research on the 14-3-3η auto-antibody test at #SpondyloCongress 2024 in Ghent, Belgium. Join us on Sep 6th as we explore its potential in advancing #AxSpA diagnosis and care. #AS #axialSpa

Learn more bit.ly/spa-congress
Augurex (@augurex) 's Twitter Profile Photo

Do you have persistent joint pain? Act quickly before joint damage occurs. Find out if you're at risk of Rheumatoid Arthritis. bit.ly/are-you-at-ris…

Do you have persistent joint pain? Act quickly before joint damage occurs. Find out if you're at risk of Rheumatoid Arthritis.
bit.ly/are-you-at-ris…
Augurex (@augurex) 's Twitter Profile Photo

Augurex is proud to announce its successful certification under the Medical Device Single Audit Program (MDSAP), an important step forward in our commitment to global quality and regulatory excellence. #AxSpA #axialspondyloarthritis #RA Learn more: augurex.com/augurex-achiev…

Augurex is proud to announce its successful certification under the Medical Device Single Audit Program (MDSAP), an important step forward in our commitment to global quality and regulatory excellence. #AxSpA #axialspondyloarthritis #RA

Learn more: augurex.com/augurex-achiev…
Augurex (@augurex) 's Twitter Profile Photo

High levels of 14-3-3η can inform poor prognosis and mark more rapid progression. These higher risk patients, tightly managed, can achieve remission with escalated first-line treatment. augurex.com/prevent-perman…

High levels of 14-3-3η can inform poor prognosis and mark more rapid progression. These higher risk patients, tightly managed, can achieve remission with escalated first-line treatment.
augurex.com/prevent-perman…
Augurex (@augurex) 's Twitter Profile Photo

September is #ArthritisAwarenessMonth! We're proud of our work in #RA & #AxSpA—advancing research & presenting at global conferences. Support advocacy groups like Arthritis Society Canada, Arthritis Foundation, & ASIF. Learn more, donate, & volunteer to make a difference! #ArthritisAwareness

September is #ArthritisAwarenessMonth! We're proud of our work in #RA &amp; #AxSpA—advancing research &amp; presenting at global conferences. Support advocacy groups like <a href="/ArthritisSoc/">Arthritis Society Canada</a>, <a href="/ArthritisFdn/">Arthritis Foundation</a>, &amp; <a href="/ASIntFed/">ASIF</a>. Learn more, donate, &amp; volunteer to make a difference! #ArthritisAwareness